Consensus Lunit Inc.

Equities

A328130

KR7328130000

End-of-day quote Korea S.E. Other stock markets 03:30:00 24/05/2024 am IST			5-day change	1st Jan Change
56,900 ^KRW	-1.04%		+4.02%	-30.53%

24/05	Lunit to Showcase 7 Studies at Asco 2024, Including Ai Innovations in Her2 Quantification, and Multimodal Predictive Models for Immunotherapy Response	CI
23/05	Lunit Acquires New Zealand's Volpara Health Technologies	MT

Evolution of the average Target Price on Lunit Inc.

Price target over the last 5 years

History of analyst recommendation changes

58e265346e6262d6c6bedbb510d74.XAACDAfQ2W2a0pC4AG8XFUggMH8lUcwnOgZ-nYNVndo.DmhafmHjmFqu6_2PSiImTSNZXjhvPLZ_dEpMyuYZy7cXc288f7buWtm60Q~27e843cb0df4edc63f3f327d94cf180c

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

56,900 KRW

Average target price

1,00,000 KRW

Spread / Average Target

+75.75%

High Price Target

1,00,000 KRW

Spread / Highest target

+75.75%

Low Price Target

1,00,000 KRW

Spread / Lowest Target

+75.75%

Consensus detail

Consensus revision (last 18 months)

Ratings for Lunit Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Annual profits - Rate of surprise

Company calendar